Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.

[1]  Y. Beguin.  Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer. , 1998, Medical oncology.

[2]  D. Amadori,et al.  Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  C. Helmers,et al.  Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Fillet,et al.  Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. , 1998, Haematologica.

[5]  M. Cazzola,et al.  Use of recombinant human erythropoietin outside the setting of uremia. , 1997, Blood.

[6]  G. Leone,et al.  High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration. , 1997, British Journal of Cancer.

[7]  A. Bosi,et al.  High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study. , 1997, Haematologica.

[8]  A. Bosi,et al.  Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial. , 1996, Bone marrow transplantation.

[9]  G. Juliusson,et al.  Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma. , 1996, Blood.

[10]  G. Scambia,et al.  The combination of erythropoietin and granulocyte colony‐stimulating factor increases the rate of haemopoietic recovery with clinical benefit after peripheral blood progenitor cell transplantation , 1996, British journal of haematology.

[11]  G. Juliusson,et al.  Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma : A randomized multicenter study , 1996 .

[12]  Gerard N. Jager,et al.  Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. , 1995, Blood.

[13]  C. Fegan,et al.  Serum erythropoietin during autologous bone marrow transplantation: relationship to measures of erythroid activity. , 1995, Clinical and Laboratory Haematology.

[14]  B. Sautois,et al.  Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant reatment with recombinant human erythropoietin , 1995, British journal of haematology.

[15]  J. Szer,et al.  Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group. , 1995, Bone marrow transplantation.

[16]  M. Cazzola,et al.  Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.

[17]  F. Mandelli,et al.  A controlled trial of recombinant human erythropoietin after bone marrow transplantation. , 1994, Blood.

[18]  B. W. Brown,et al.  A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. , 1994, Blood.

[19]  G. Demetri,et al.  Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation , 1994, British journal of haematology.

[20]  R. Saccardi,et al.  Down-modulation of serum erythropoietin levels following cyclosporin A infusion. , 1994, Bone Marrow Transplantation.

[21]  P. Ljungman,et al.  Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin. , 1994, Bone marrow transplantation.

[22]  F. Locatelli,et al.  Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. , 1994, Bone marrow transplantation.

[23]  M. Cazzola,et al.  Accelerated erythroid repopulation with no stem‐cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation , 1993, British journal of haematology.

[24]  A. Bosi,et al.  Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line. , 1993, Blood.

[25]  G. Fillet,et al.  Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. , 1993, Bone marrow transplantation.

[26]  G. Fillet,et al.  Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. , 1993, Blood.

[27]  W. Ebell,et al.  Effect of recombinant human erythropoietin after allogenic bone marrow transplantation. , 1993, Annals of hematology.

[28]  M. Otero,et al.  Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial. , 1992, Bone marrow transplantation.

[29]  S. Piantadosi,et al.  Impaired erythropoietin response to anemia after bone marrow transplantation. , 1992, Blood.

[30]  K. Strohl,et al.  Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. , 1992, Bone marrow transplantation.

[31]  Abels Ri.  Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. , 1992 .

[32]  A. Bosi,et al.  Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients. , 1992, Leukemia.

[33]  Abels Ri,et al.  Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. , 1992, Seminars in oncology.

[34]  D. Norfolk,et al.  Changes in serum erythropoietin levels during allogeneic bone marrow transplantation , 1991, European journal of haematology.

[35]  A. Bosi,et al.  Inadequate erythropoietin production in allogeneic bone marrow transplant patients. , 1991, Haematologica.

[36]  Erslev Aj.  Erythropoietin titers in health and disease. , 1991 .

[37]  L. Vannucchi,et al.  Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation. , 1991, Bone marrow transplantation.

[38]  A. Erslev.  Erythropoietin titers in health and disease. , 1991, Seminars in hematology.

[39]  G. Fillet,et al.  Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. , 1991, Blood.

[40]  A. Bosi,et al.  Impaired erythropoietin production in mice treated with cyclosporin A. , 1991, Blood.

[41]  M. Goldberg,et al.  Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. , 1990, Blood.

[42]  K. Atkinson,et al.  Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients , 1990, British journal of haematology.

[43]  P. Greenberg,et al.  Effects of CSFs in preleukemia. , 1990, Bone marrow transplantation.

[44]  O. Ringdén,et al.  Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. , 1990, Bone marrow transplantation.

[45]  G. Birgegard,et al.  Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation , 1989, British journal of haematology.

[46]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[47]  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. , 1987, The New England journal of medicine.

[48]  L. G. Lee,et al.  Thiazole orange: a new dye for reticulocyte analysis. , 1986, Cytometry.